Transitional Palliative Care in End-stage Heart Failure

Heart Failure Clinical Trial

Official title:

Effects of a Transitional Palliative Care Model on Patients With End-stage Heart Failure

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02086305
• Other study ID #: PolyU5492
• Status: Completed
• Phase: N/A
• First received: March 7, 2014
• Last updated: August 21, 2017
• Start date: January 2013
• Est. completion date: December 2016

Study information

• Verified date: August 2017
• Source: The Hong Kong Polytechnic University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Palliative care for end-stage organ failure patients has been included as one of the key programs to be implemented in 2011-2012 in the Hospital Authority, Hong Kong. Among all the disease groups, end-stage heart failure patients have the highest mortality rate. Patients at the end stage of heart failure have health concerns shared by other end-stage patients including cancer patients. Many guidelines, local and world-wide, have advocated a palliative approach of care for those heart failure patients who are at end stage. Studies have shown that end-stage heart failure patients tend to have frequent emergency room visits and repeated hospital admissions. Also, these patients suffer from a number of health problems that adversely affect their Quality Of Life.

There is scarcity of experimental studies informing practitioners which models work best for palliative patients in Hong Kong. There were randomized controlled trials conducted outside Hong Kong which suggest multidisciplinary approach of palliative care is possible to reduce readmissions but evidence is not present for other outcomes such as symptom control and carer burden.

In an attempt to fill knowledge gap and inform practice using evidence, this study is launched to compare the effects of a customary hospital-based palliative heart failure care and an interventional Home-based Palliative heart failure Program.

Hypothesis

• there is no difference in health care utilization for end-stage heart failure patients between the customary hospital-based group and the Home based palliative heart failure program group

• there is no difference in evaluated health outcomes (functional status, symptom intensity, and satisfaction with care) between the customary hospital-based group and the Home based palliative heart failure program group

• there is no difference in perceived health outcomes (quality of life, caregiver burden) between the customary hospital-based group and the Home based palliative heart failure program group

• there is no difference in cost effectiveness between the customary hospital-based group and the Home based palliative heart failure program group

• there is no difference In patients' lived experiences between the customary hospital-based group and the Home based palliative heart failure program group

Description:

As described

Recruitment information / eligibility

• Status: Completed
• Enrollment: 84
• Est. completion date: December 2016
• Est. primary completion date: February 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Ability to speak Cantonese

• Living within the hospital service area

• Ability to be contacted by phone

• Identified as end-stage heart failure eligible for palliative care, guided by Prognostic Indicator Guidance, National Gold Standards Framework,to fulfill at least two of the indicators below:

(i) Congestive heart failure New York Heart Association stage III or IV (ii) Patient thought to be in the last year of life by the care team (iii) Repeated hospital admissions with symptoms of heart failure (3 hospital admissions within one year) (iv) Existence of physical or psychological symptoms despite optimal tolerated therapy

Exclusion Criteria:

• Discharged to nursing home or other institution

• Inability to communicate

• Diagnosed with severe psychiatric disorders such as schizophrenia, bipolar disorder

Related Conditions & MeSH terms

• End Stage Heart Disease
• Heart Diseases
• Heart Failure

Intervention

Behavioral:
• Transitional Care Model
Symptom assessment and management, care goal setting, post-discharge support
• Usual care
Usual care is the routine practice in the hospital

Locations

Country	Name	City	State
Hong Kong	Grantham Hospital	Hong Kong
Hong Kong	Haven Of Hope Hospital	Hong Kong
Hong Kong	United Christian Hospital	Hong Kong

Sponsors (1)

Lead Sponsor	Collaborator
The Hong Kong Polytechnic University

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Healthcare utilization	The time from hospital discharge to hospital readmission using hospital clinical management system to retrieve data	up to 12 months
Secondary	Quality of Life	Change from baseline in quality of life on the palliative specific McGill Quality of Life Questionnaire Hong Kong version (MQOL-HK) at 1 month; change from baseline in MQOL-HK at 3 months; change from baseline in MQOL-HK at 6 months; change from baseline in MQOL-HK at 12 months	baseline, 1 month, 3 months, 6 months, 12 month
Secondary	Quality of Life	Change from baseline in quality of life on the heart failure specific Chronic Heart Failure Questionnaire-Chinese version (CHQ) at 1 month; change from baseline in CHQ score at 3 months; change from baseline in CHQ score at 6 months; change from baseline in CHQ score at 12 months	Baseline, 1 month, 3 months, 6 months, 12 months
Secondary	Functional status	Change from baseline in functional status on the Palliative Performance Scale (PPS) at 1 month; change from baseline in PPS at 3 months; change from baseline in PPS at 6 months; change from baseline in PPS at 12 months	Baseline, 1 month, 3 months, 6 months, 12 months
Secondary	Symptom intensity	Change from baseline in symptom intensity on the Edmonton Symptom Assessment System (ESAS) at 1 month; change from baseline in ESAS score at 3 month; change from baseline in ESAS score at 6 month; change from baseline in ESAS score at 12 month.	Baseline, 1 month, 3 month, 6 month, 12 month
Secondary	Satisfaction with care	Change from 1 month in satisfaction with care on the 15-item questionnaire developed by the principal investigator which validity confirmed by an expert panel and reported test-retest reliability of .87 (Sat-care) at 3 month; change from 1 month in Sat-care score at 6 months; change from 1 month in Sat-care score at 12 months	1 month, 3 months, 6 months, 12 months
Secondary	Caregiver burden	Change from baseline in caregiver burden on the Zarit Caregiver Burden Scale (ZCBS) at 1 month; change from baseline in ZCBS score at 3 months; change from baseline in ZCBS score at 6 months; change from baseline in ZCBS score at 12 months	Baseline, 1 month, 3 months, 6 months, 12 months